Enterprise Value
N/A
Fri, 21 Feb 2025 23:32:15 GMT
Summary
- HALO enterprise value is not available.
Performance
HALO Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
HALO Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | - | -0.5% | -0.5% |
| 1 m1 month | - | -3.6% | -3.6% |
| 3 m3 months | - | +19.2% | +23.1% |
| 6 m6 months | - | -11.2% | -8.6% |
| ytdytd | - | +18.2% | +18.2% |
| 1 y1 year | - | +38.1% | +42.2% |
| 5 y5 years | - | +132.2% | +160.6% |
HALO Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | $7.71 B | $7.23 B | ||
| 6 m | 6-month | $9.55 B | $6.21 B | ||
| 1 y | 1-year | $9.55 B | $6.06 B | ||
| 3 y | 3-year | $9.55 B | $5.26 B | ||
| 5 y | 5-year | $9.55 B | $2.20 B | ||
| alltime | all time | $9.55 B | $51 M |
Halozyme Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2023 | $6.07 B(-32.2%) |
| 2022 | $8.95 B(+42.3%) |
| 2021 | $6.29 B(+4.5%) |
| 2020 | $6.02 B(+122.3%) |
| 2019 | $2.71 B(+23.8%) |
| 2018 | $2.19 B(-25.3%) |
| 2017 | $2.93 B(+104.7%) |
| 2016 | $1.43 B(-35.8%) |
| 2015 | $2.23 B(+85.4%) |
| 2014 | $1.20 B(-30.9%) |
| Date | Value |
|---|---|
| 2013 | $1.74 B(+152.8%) |
| 2012 | $687.89 M(-26.5%) |
| 2011 | $936.11 M(+31.2%) |
| 2010 | $713.34 M(+51.5%) |
| 2009 | $470.71 M(+20.0%) |
| 2008 | $392.37 M(-14.0%) |
| 2007 | $456.22 M(-10.4%) |
| 2006 | $509.14 M(+462.5%) |
| 2005 | $90.52 M(-1.9%) |
| 2004 | $92.24 M |
FAQ
- What is the all time high enterprise value for Halozyme Therapeutics?
What is the all time high enterprise value for Halozyme Therapeutics?
Halozyme Therapeutics all-time high enterprise value is $9.55 B